Lilly Medical US

Explore the various ways to “Ask Lilly.” This includes LillyMedical.com, our website for healthcare professionals that shares our scientific presentations, publications, and educational materials. We’re here to help!

Welcome to AAIC 2025! We're excited to share our latest research in Alzheimer's disease. The Lilly Medical Neuroscience team is ready to answer your questions. Learn more: e.lilly/3HJqyUT

Results from the Phase 3 VIVID-1 study on fatigue outcomes in Crohn’s disease now available in the Journal of Crohn’s and Colitis: e.lilly/4lFv8C2

Psoriatic arthritis treatment often involves addressing coexisting health issues such as obesity, hypertension, metabolic syndrome, and more as part of a comprehensive care plan. Click here to learn more: e.lilly/4lPW425

Calling all registered DERM2025 Attendees! Join Adam Friedman MD, FAAS, in our upcoming symposium session “Expert to Experts” on Wednesday, July 23rd from 3:30PM-4:00PM. View the full agenda: e.lilly/44vEVoy

Swipe to explore two unique resources: Maria’s case in our ConnectAD Clinical Cases, and Dr. Cohen’s demonstration of effective communication during the diagnosis of mild cognitive impairment due to Alzheimer’s disease. Click to view the cases here: e.lilly/4kvVHsA

Thank you to all who joined us in San Francisco, CA at ENDO 2025! Attendees can learn more about the obesity research we presented at our Lilly Congress Hub: e.lilly/4kz1Jsy

New Results from the ACHIEVE-1 Phase 3 Study of a GLP-1 receptor agonist in early type 2 diabetes Click here to read the full study: e.lilly/4koQ9QF

We are excited to join the endocrine community at ENDO 2025! Visit us at Medical Booth 1509 or head to our Lilly Congress Hub to explore our obesity research. Learn more: e.lilly/3Iq0gqV

AWIR2025 Attendees! On Saturday, July 26th from 08:45 to 09:15am EST join us for our live symposium exploring the relationship between Obesity and Psoriatic Arthritis presented by Dr. Catherine Bakewell. Learn more here: e.lilly/3T5gmIF

QWINT-1 is now published in New England Journal of Medicine! Click here to read the full study: e.lilly/4lBcz22

Why do you think Atopic Dermatitis (AD) is an IL-13 dominant disease? Explore the role of IL-13 in AD here: e.lilly/4k6oyn3

Connect with Mateo’s case in our ConnectAD Clinical Cases, and discover how to build meaningful connections and ensure clear communication for better treatment outcomes for patients, like Mateo, living with mild dementia due to #Alzheimers disease. Connect:…

Thanks for joining us at #ADA2025! Catch up on any research you may have missed or explore the latest #diabetes and #obesity science on the Lilly Medical Congress Hub. Learn more: e.lilly/3GhD2m6

What’s good for the heart is good for the brain. This downloadable resource supports early assessment, lifestyle changes & care planning to help protect cognitive health. Learn more: e.lilly/43ZUEuy #Alzheimers #Neuroscience

What are the outcomes of a comprehensive #CrohnsDisease management approach? Improved patient outcomes: fewer hospitalizations and surgeries, less treatment switching, reduced steroid use, and fewer flares. HCPs can learn more here: e.lilly/3T7PGqV

Join us virtually on Wednesday, June 25 from 8:00 – 9:00 PM EDT for an expert-led webinar on “How to Discuss and Manage Obesity With Your Patients.” Register here: e.lilly/3ZByBcm #Obesity

Join us at our #ADA2025 Oral Presentations to explore new research that is informing the future of #Diabetes care. Learn More: e.lilly/3FZpETw

Join the conversation at the ADA 85th Scientific Sessions as we explore new science in #obesity and #diabetes at our upcoming oral presentations. Learn More: e.lilly/4kFqzHR #ADA2025

How does #Alzheimers disease progress—and why does early recognition matter? This downloadable resource breaks down the continuum into key clinical stages and illustrates the importance of early recognition in optimizing patient care. Download here: e.lilly/3SD17X2…

New #Obesity Publication → Head-to-Head Study Comparing Dual and Single Incretin Receptor Agonists in Obesity Treatment Click here to read the full study: e.lilly/4dMJBto #obesityresearch #obesitymedicine